Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,427,868
+$23,432,628 QoQ
Shares Held
221,720
+39.7% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
6.57%
of 13F equity value
Holder Rank
#50
of 640 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tri Locum Partners LP holds $480,651,345 across 12 Biotechnology names. JAZZ ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
201,791 | $100,235,643 | |
| 2 | ASND |
Ascendis Pharma A/S
|
258,740 | $69,011,132 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
219,308 | $53,680,019 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
221,720 | $53,427,868 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
866,716 | $43,985,837 | |
| 6 | ARGX |
Argenx SE
|
41,596 | $38,591,520 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
68,273 | $36,659,187 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
151,822 | $28,433,224 |
All Filings in JAZZ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,427,868 | 221,720 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,995,240 | 158,663 | Shares | Sole | 2026-05-18 | |
| 2024-12-31 | $19,927,147 | 161,812 | Shares | Sole | 2025-02-14 | |
| 2022-09-30 | $14,199,117 | 106,528 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,949,201 | 57,363 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $20,342,644 | 130,678 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $15,875,686 | 89,370 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,143,489 | 110,382 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||